Fay J. Hlubocky, PhD, MA, University of Chicago Department of Medicine, discusses the concerns about death that young adult survivors face.
Rapid response teams (RRT) are used extensively in many hospitals, including major cancer centers; however, research shows that adverse outcomes are more common for patients who require RRT intervention than among the general hospital population.
Elaine DeMeyer, managing editor, inPractice Oncology, explains the benefits of the resource for oncology nurses practicing in the field.
Cancer-related cognitive impairments affect many survivors of the disease, and can have major impacts on their daily living.
Joanna Morales from the Cancer Legal Resource Center on Common Cancer Related Legal Issues
Sam didn’t understand the scope or severity of his illness until his nurse navigator intervened.
DCGs experience higher levels of anxiety and mood disturbance compared with local caregivers. On top of dealing with the expected stress of having a loved one who received a diagnosis of cancer, DCGs describe feelings of uncertainty, guilt, anxiety, and stress specifically related to their distance from the patient.
Caitlin Braithwaite, BAN, RN, OCN, University of Iowa Hospitals and Clinics, discusses her use of hand massage in patients with cancer, and what her fellow nurses thought of the implementation.
How does financial toxicity affect patients, and what can nurses do to help?
Retirement planning often never goes according to plan, but many oncology nurses are facing a retirement dilemma forced upon them by decisions from the higher levels of their respective health systems.
Ryan Nipp, MD, Massachusetts General Hospital, discusses the correlation between symptom burden and length of hospital stay for patients with cancer.
Drama therapy may be a unique approach to help patients with cancer express themselves and improve their emotional well-being. It can also help health care professionals improve their communication skills.
Fran Cartwright, PhD, RN-BC, AOCN, Senior Director of Nursing, Oncology Services and Medicine, NYU Langone Medical Center, discusses the importance of understanding the many facets of pain management.
Sometimes the most productive thing we can do is to stop.
At a median follow-up of 33.3 months, the median overall survival was not evaluable with cemiplimab, vs 20.7 months with chemotherapy alone, in this patient subset.
We need to either do away with the pink or change the color for inflammatory breast cancer (IBC), because it's not at all pink. It's black and blue, purple, and sometimes just plain red.
We were thrilled to cohost the Colorectal Cancer Survivor Panel Lunch & Learn at the recent OMG! Cancer Summit for Young Adults with our friends at Chris4Life.
Language barriers can mean patients put off preventive screenings, and even treatment, for fear of being misunderstood by their healthcare providers.
Newly standardized grading criteria will help to regulate the management of CAR T-cell therapy¬–related toxicities, like cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS).
A phase 3 trial designed to evaluate eprenetapopt plus azacytidine (Vidaza) in patients with TP53-mutant positive myelodysplastic syndrome (MDS) completed full enrollment, according to Aprea Therapeutics, Inc.
Jan Lewin, PhD, section chief of Speech Pathology at the University of Texas MD Anderson Cancer Center, discusses head and neck lymphedema.
Nickhill Bhakta, MD, fellow at St. Jude Children’s Research Hospital, discusses some unanswered questions about late effects of adult survivors of childhood cancer.
Over the past several years, process improvements in the care of our oncology patients have been implemented that focus on the provision of safe and high quality clinical care and employee safety.
Some nurses share how they handle such remarks.
Claire Snyder, MHS, PhD, associate professor of medicine and oncology with a joint appointment in health policy and management at Johns Hopkins School of Medicine, discusses patient-reported outcome assessments and standardization of questionnaires.
Jyoti Patel, MD, of Northwestern University's Feinberg School of Medicine, talks about the subject of delaying whole brain radiation for brain metastases.
Ragini Kudchadkar, MD, explains what nurses should keep in mind when treating patients with basal cell carcinoma.
Rajni Kannan, BS, MS, RN, ANP-BC, discusses some risk factors for melanoma that may not be widely known.
A team of researchers at the University of Pittsburgh School of Nursing set out to better understand the interpersonal communication components of breast cancer navigation services.